UBS · REGN Holdings Trend
Regeneron Pharmaceuticals · SEC 13F
UBS Holdings of REGN by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 942K | $907M | — |
| 2024Q2 | 1.1M | $1.2B | +27.8% |
| 2024Q3 | 1.0M | $1.1B | -6.8% |
| 2024Q4 | 1.4M | $972M | -9.9% |
| 2025Q1 | 1.2M | $779M | -19.9% |
| 2025Q2 | 1.2M | $606M | -22.2% |
| 2025Q3 | 1.1M | $609M | +0.6% |
| 2025Q4 | 1.0M | $785M | +28.8% |
| 2026Q1 | 1.0M | $791M | +0.8% |
← Back to REGN holders ← Back to REGN profile
Data source: SEC EDGAR Form 13F